miércoles, 25 de febrero de 2026
Will Novo Nordisk’s slashing of obesity drug prices save patients’ money? It depends Experts say some will benefit from cuts to list prices, but it’s net prices that often matter more
https://www.statnews.com/2026/02/24/novo-nordisk-weight-loss-drug-price-cut-examined/
By Elaine ChenFeb. 24, 2026
Elaine Chen, a national biotech reporter, is the co-author of The Readout, a newsletter about the business, science, and politics of biotech.
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario